Special Issue "Tumors of the Central Nervous System: An Update"
A special issue of Cancers (ISSN 2072-6694).
Deadline for manuscript submissions: closed (30 November 2019).
Tumors of the central nerovus system include entities that originate from different cell types and affect various structures. The 2016 WHO classification lists a variety of tumors, further specified by different grading associated with histological, genetic, and molecular features.
While the well-known glioblastoma increasingly attracts interest, many other tumors are almost neglected. However, even non-malignant tumors may have a strong impact on brain structure and functions. Hence, strategies aimed at blocking their development are needed, as well as fundamental knowledge on tumor cell functions and interactions with the surrounding tissue. Understanding the biology of the different tumors of the central nerovus system may pave the way to innovative therapies.
The present Special Issue aims at increasing our knowledge about intracellular pathways and interactions between different cells and brain structures, in order to plan successful strategies against these diseases of the brain. This Special Issue is open to contributions from experimental and clinical studies, including reports on improved experimental models and innovative therapies.
Dr. Carla Mucignat
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- phenotypic diagnostics
- molecular markers
- cell–cell interactions